Notable Analyst Rating Changes 11/28: THC, STD, FRO Upgraded; CHU, BCE, OVTI Downgraded

November 28, 2008 9:57 AM EST

UPGRADES:
UBS upgrades Tenet Healthcare (NYSE: THC) from Sell to Neutral.

UBS upgrades Banco Santander (NYSE: STD) from Sell to Neutral.

UBS upgrades Frontline (NYSE: FRO) from Sell to Neutral.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES:
Credit Suisse downgrades China Unicom (NYSE: CHU) from Neutral to Underperform.

UBS downgrades BCE (NYSE: BCE) from Buy to Neutral.

Caris & Co. downgrades OmniVision Technologies (Nasdaq: OVTI) from Buy to Average.

For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades

NEW COVERAGE:
Thomas Weisel initiates coverage on Cameco (NYSE: CCJ) with a Market Weight rating and a $22 price target.

Deutsche Bank reinstates coverage on BHP Billiton (NYSE: BHP) with a Buy.

Canaccord Adams initiates coverage on BCE (NYSE: BCE) with a Hold.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Create E-mail AlertRelated Categories

Special Reports

Stocks Mentioned

Related Entities

• Credit Suisse
• Deutsche Bank
• UBS
• Canaccord Adams
• Thomas Weisel Partners Group
• Notable Analyst Rating Changes

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?